Jeanne Fourie Zirkelbach

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with <i>RET</i> Gene Mutations or Fusions

Diana Bradford, Erin Larkins, Sirisha L. Mushti et al. · Clinical Cancer Research · 2020 · 167 citations

Medicine, Oncology, Molecular Oncology +12

FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer

Amanda J. Walker, Suparna Wedam, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2016 · 137 citations

Medicine, Oncology, Pharmacology +17

FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic Melanoma

Amy Barone, Maitreyee Hazarika, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 87 citations

Medicine, Oncology, Pharmacotherapy +12

FDA Approval Summary: Selpercatinib for the Treatment of Advanced <i>RET</i> Fusion-Positive Solid Tumors

Elizabeth S. Duke, Diana Bradford, Michelle Marcovitz et al. · Clinical Cancer Research · 2023 · 82 citations · Full text

Medicine, Oncology, Molecular Oncology +13

Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Who Have Previously Received Docetaxel: U.S. Food and Drug Administration Drug Approval Summary

Yang‐Min Ning, William F. Pierce, V. Ellen Maher et al. · Clinical Cancer Research · 2013 · 66 citations

Medicine, Oncology, Pharmacology +16